US FDA’s Top Two Vaccine Officials Announce Surprise Retirements

Departures of Marion Gruber and Philip Krause may stem from White House and CDC actions related to the COVID-19 vaccines.

FDA-White House-Covid boosters (nielsen hobbs)
The retirement announcements have put a focus on the FDA/White House interplay regarding COVID vaccines. • Source: Nielsen Hobbs

The top two senior officials in the US Food and Drug Administration’s vaccine review and approval operation plan to retire this fall, potentially adding to the agency’s challenges as it works to clear the coronavirus vaccines in children and booster shots for adults.

Marion Gruber, director of the Center for Biologics Evaluation and Research’s Office of Vaccines Research and Review, plans to leave...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet